EPIRUBICINE VIATRIS 2 mg/ml, solution pour perfusion/solution intravésicale

( ARTG ) SICAL is indicated for the treatment of established osteoporosis diagnosed by objective measuring techniques, such as densitometry, or by radiographic evidence of atraumatic fracture.​​​‍​​‍​​​​‍​​‍‍ SICAL a is also indicated for the prevention of corticosteroid-induced osteoporosis in patients commencing oral steroid therapy in a dose and regimen expected to result in a significant bone loss. SICAL is indicated in the treatment of hypocalcemia in patients with uremic osteodystrophy, hypoparathyroidism and in hypophosphataemic rickets.